Accacia International LLC provides expertise and capabilities in the field of research, development and commercialization of rapid diagnostic bioassays and detection instruments for the clinical, veterinary, agricultural and bio-defense markets. The firmâs core competency is based on solid or liquid phase bimolecular detection utilizing reflectance, fluorescence intensity and fluorescence polarization technologies. The firms AccaciaGold technology is a point-of-care diagnostic platform designed to dia'gnose infectious disease like Tuberculosis, Dengue & West Nile Virus. The device uses an isothermal amplification based assay to detect nucleic acid signatures that are exclusively found in pathogens. The firm also has designed a portable battery powered instrument to house the assay to provide a complete platform. The potential for this device is huge for developed regions to limited resource areas. This device requires no specialized equipment and a minimum of technical training
